This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, with a ceiling value of $2,740.49 and a period of performance ending on May 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of PROQUAD VIALS, a medical product, with a ceiling value of $3,341.80 and a period of performance ending on May 19, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a type of medical product, with a ceiling value of $1,687.48 and a period of performance through April 23, 2025. This contract is not set aside and is considered an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of PROQUAD VIALS, a medical product, with a ceiling value of $1,687.48 and a period of performance through March 2025. The contract is a firm fixed-price delivery order, and there was no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,670.90, is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a completion date of May 19, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The contract has a total ceiling value of $1,687.48 and is a firm fixed-price, non-set-aside contract with a performance period through May 16, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the product "PROQUAD VIALS." The contract has a ceiling value of $45,135.90 and is a firm-fixed price delivery order contract with a period of performance ending on September 26, 2024. Amerisourcebergen has been awarded this contract without a set-aside designation, leveraging its extensive supply chain and capabilities to provide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for PROQUAD VIALS, a medical supply, with a firm fixed price ceiling value of $1,601.99. The contract has an ultimate completion date of October 4, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,687.48, is for the delivery of PROQUAD VIALS, a type of medical product. The contract is a firm fixed-price delivery order with a performance period ending on May 23, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,962.99, is for the delivery of PROQUAD VIALS, a medical product. The contract has a firm fixed price pricing type and a performance period ending on May 13, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...